No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ALT240628C4500
- 2.07
- -1.43-40.86%
15min DelayClose Jun 28 15:59 ET
2.08High2.05Low
2.05Open3.50Pre Close100 Volume103 Open Interest4.50Strike Price20.57KTurnover0.00%IV-1.20%PremiumJun 28, 2024Expiry Date2.15Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.18Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics
If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy
Express News | Shares of Altimmune Are Trading Higher After a NYPost Article Highlighted a Study Comparing the Company's Pemvidutide to Ozempic
Express News | Watching Altimmune; Traders Circulate New Yor Post Article 'New Weight Loss Drug May Be Better Than Ozempic — Here's How'
Why Are Altimmune Shares Trading Lower Wednesday?
Altimmune Drops 15% After Sudden Death of Finance Chief
Comments
$Altimmune(ALT.US$ hopefully just a steady rise from here
$Altimmune(ALT.US$ cheers to those who saw it coming 👌🏾
4
$Altimmune(ALT.US$ waiting for this breakout
3
$Altimmune(ALT.US$ DEATH CROSS
4
Read more